HOME >> MEDICINE >> NEWS
Statin therapy cost-effective for a wider range of individuals

Statin therapy is cost-effective for a wider range of individuals with vascular disease or diabetes than previously recognised, concludes a study published online today (Thursday May 12, 2005) by THE LANCET.

Current guidelines generally recommend the initiation of statin therapy when the estimated 10-year risk of a non-fatal heart attack or coronary death is at least 15-20%.

The Heart Protection Study (HPS) has previously shown that lowering cholesterol concentrations with 40mg of simvastatin daily produces substantial reductions not just in the rates of such coronary events, but also in the rates of strokes and revascularisation procedures among a wide-range of high-risk individuals, irrespective of their pre-treatment blood cholesterol concentrations. In the HPS, over 20,500 adults aged 40-80 years with vascular disease or diabetes were randomly assigned to 40mg of simvastatin daily or a placebo. In the latest study the HPS researchers compared the costs of hospitalisations and statin therapy between the two groups, and estimated the cost-effectiveness for participants with varying levels of vascular disease risk.

They found a 22% relative reduction in the costs of hospitalisations for vascular events in the statin group, with similar proportional reductions in every sub-category of patients studied. Overall, the cost of avoiding a major vascular event was estimated to be 11,600, but there was substantial variation between the risk subgroups. For example, among individuals with a 42% 5-year risk of a major vascular event, the estimated cost-effectiveness was 4,500 per major vascular event avoided. By contrast, among those with a 12% 5-year risk, it was estimated to be 31,100. The authors believe that initiation of statin therapy should now be considered for people at lower risk for coronary or other major vascular events than is currently recommended.

Professor Rory Collins (Clinical Trial Service Unit, University of Oxford, UK), p
'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
1-212-633-3810
Lancet
11-May-2005


Page: 1 2

Related medicine news :

1. Statin drugs may delay progressive artery damage in children
2. Statin use linked with decreased prostate cancer mortality rates, lower PSA levels
3. Statins linked to lower risk of infection
4. Statin users risk heart attacks by dropping treatment or taking low doses
5. Statins protect smokers from lung damage
6. Statins reduce risk of stroke in heart patients
7. Statin use associated with reduced risk of common type of cataract
8. Statins prove life-saving in patients with acute coronary syndromes
9. Statins may improve circulation in the retina
10. Statins, beta-blockers lessen heart attack risk, says Stanford-Kaiser study
11. Statins have neutral effect on risk of cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2018)... ... December 07, 2018 , ... ... critical juncture in world affairs, U.S. leadership and funding at the United Nations ... years—great strides in reducing extreme poverty and advancing global health plus meaningful reforms ...
(Date:12/6/2018)... RATON, Fla. (PRWEB) , ... December 06, 2018 ... ... those unable to cope with day-to-day life, there are alternative solutions. M.D.-formulated Relaxium ... , Relaxium Calm ’s main ingredient is Sensoril®, an extract of the ...
(Date:12/5/2018)... ... 2018 , ... Body by Ravi Plastic Surgery and Aesthetics ... to offer the BodyTitePRO treatment. Dr. Ravi Somayazula , practice founder, has ... noninvasive techniques to improve the face, breast and body. Together with his partner, ...
(Date:12/5/2018)... Ill. (PRWEB) , ... December 05, 2018 , ... ... CRO, FSP, Strategic Resourcing, and Consulting services, announced its new office location in ... will accommodate organic growth of clinical trial operations in Europe and additional in-country ...
(Date:12/5/2018)... ... December 05, 2018 , ... ... (HM). In this role, he will be responsible for the executive oversight of ... “We conducted an extensive, nationwide search for this position,” Tom Doran, president, HM ...
Breaking Medicine News(10 mins):
(Date:12/5/2018)... SIOUX FALLS, S.D. (PRWEB) , ... December 05, 2018 , ... ... of the inaugural $1 million Sanford Lorraine Cross Award. , Jean Bennett, M.D., ... an inherited form of blindness, accepted the award on Dec. 4 at Sanford Health, ...
(Date:11/29/2018)... HOLLYWOOD, Calif. (PRWEB) , ... November 29, 2018 , ... ... rehabilitation center located in North Hollywood, CA, announced today they were selected by ... California to participate in a new Volunteer Engagement Project. , The California Department ...
(Date:11/28/2018)... THE WOODLANDS, Texas (PRWEB) , ... November 28, ... ... from Rigaku Corporation has been published and is available to ... newsletter concentrating on single crystal X-ray diffraction, published by Rigaku Oxford Diffraction ...
Breaking Medicine Technology:
Cached News: